RECURRENT PLEURAL MALIGNANT MESOTHELIOMA
Clinical trials for RECURRENT PLEURAL MALIGNANT MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PLEURAL MALIGNANT MESOTHELIOMA trials appear
Sign up with your email to follow new studies for RECURRENT PLEURAL MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail offers hope for rare cancers
Disease control OngoingThis study tests a combination of two drugs, atezolizumab and bevacizumab, in people with rare solid tumors that are hard to treat. The goal is to see if the drugs can shrink or control the cancer by boosting the immune system and blocking tumor blood supply. About 133 adults wit…
Matched conditions: RECURRENT PLEURAL MALIGNANT MESOTHELIOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control OngoingThis study tests whether adding a drug called methoxyamine (TRC102) to standard chemotherapy can help shrink tumors in people with advanced solid tumors or mesothelioma that have not responded to other treatments. The goal is to make cancer cells more sensitive to chemo. About 30…
Matched conditions: RECURRENT PLEURAL MALIGNANT MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:38 UTC